Meyer Introduces First Pediatric Tuberculosis Formulation in Italy
Florence hospital Meyer has introduced Italy’s first pediatric formulation for treating tuberculosis in children, bringing dispersible, weight-appropriate doses to young patients who previously relied on crushed adult pills, according to reports by ANSA. The initiative changes national pediatric care by replacing customized adult therapies that carried risks of incorrect dosing and difficult administration over months-long treatment cycles.
For us this is a beautiful revolution, because until today we have had difficulty treating children sick with tuberculosis,
Leila Bianchi, an infectious disease specialist at Meyer, and Lorena Di Simone, head of the hospital’s pharmacy service, explained in statements reported by both outlets.
Dispersible tablets improve treatment adherence for children
The newly available medications are dispersible tablets designed to dissolve in water for small children who struggle to swallow traditional pills. Recommended by the World Health Organization and utilized in more than 120 low- and middle-income countries, these fixed-dose combinations pack multiple active ingredients into fewer administrations to improve treatment adherence. Ten young patients are currently waiting to receive the therapies at Meyer.
The rollout relies on a public health collaboration involving Meyer’s infectious disease and hospital pharmacy units alongside the Military Chemical-Pharmaceutical Plant in Florence, directed by Colonel Arcangelo Moro. Operating as a distribution hub, the military facility stores and distributes the medications—which are imported from the Netherlands—for deployment across Italy. The initiative also involves the Stop TB Italia association, the Ministry of Health, AIFA, USMAF, and the Italian Society of Pediatric Infectiology.
Hospital plans to expand drug use for prophylaxis
Regional President Eugenio Giani stated that the milestone proves Meyer’s capacity to build innovative partnerships with regional institutions, while Health Councilor Monni emphasized that tailoring therapies to children simplifies months-long regimens for families.
Looking ahead, hospital administrators plan to expand the use of these formulations beyond active treatment. The medical team intends to deploy the dispersible drugs for prophylaxis among children who have had close contact with infected individuals, such as within school communities. Meyer Director General Federico Gelli noted that the collaborative effort establishes a secure and accessible therapeutic pathway previously unavailable in the country.
Frequently Asked Questions About the New Tuberculosis Treatments
What specific difficulties did families face with older tuberculosis treatments in Italy?
Families previously had to manage adult-strength pills that required manual splitting and manipulation to achieve fractional pediatric doses. This practice risked both inaccurate dosing and altered drug absorption, complicating months-long treatment regimens at home.
How do the new pediatric tablets work for very young patients?
The medications utilize a dispersible formulation that dissolves directly in water. This design specifically assists infants and small children who cannot swallow traditional solid pills, while fixed-dose combinations reduce the total number of daily tablets required.
Where are the new medicines manufactured and stored before reaching hospitals?
The pharmaceutical products are imported from the Netherlands and routed through the Military Chemical-Pharmaceutical Plant in Florence. The military facility serves as the national hub for storing and distributing the specialized pediatric formulations to Italian medical centers.
Keep reading